Congratulations to Susan Mooberry, Ph.D. for being awarded the the inaugural Susan Band Horwitz Award Lecture in Cancer Pharmacology!
The ASPET Division for Cancer Pharmacology is pleased to award Dr. Susan Mooberry from the University of Texas Health Science Center at San Antonio, the inaugural Susan Band Horwitz Award Lecture in Cancer Pharmacology. This award recognizes excellent original research by established investigators in cancer pharmacology. The award is named in honor of Dr. Horwitz who is a pioneer in discovering the mechanisms of action of cancer chemotherapy drugs many of which have been and remain mainstays of cancer therapy and whose work has changed the nature of cancer treatment.
Dr. Mooberry is receiving this award in recognition for her innovative research related to the identification, mechanism of action and development of natural products for the treatment of cancer and her strong track record mentoring younger scientists.
Dr. Mooberry is a Professor of Pharmacology and Interim Department Chair at the University of Texas Health Science Center at San Antonio where she also holds the Greehey Distinguished Chair in Molecular Therapeutics.
She received her PhD in pharmacology from the Medical University of South Carolina and conducted her postdoctoral studies on natural product drug discovery at the University of Hawaii where she continued as faculty and discovered three novel classes of natural product-derived microtubule targeting agents. Her laboratory has expertise in the discovery of natural products with anticancer potential and identifying the mechanisms of action of microtubule targeting agents where she has conducted foundational studies on the non-mitotic effects of these drugs. She has published extensively, holds 11 patents on new classes of anticancer drug leads, and was elected as a Fellow of the AAAS in 2020. She has been a member of ASPET since 2010.
The award will be presented by the Division for Cancer Pharmacology at the ASPET Annual Meeting at EB 2022 in Philadelphia on Monday, April 4, 2022 where Dr. Mooberry will deliver a lecture on her research titled Microtubule Targeting Drugs: So Much More Than Antimitotics.